by EpicentRx | Jul 12, 2023 | Blog
This summer Barbie—and hot pink Barbiecore—are everywhere. And so is the plastic, recycled or otherwise, that the iconic Barbie dolls, dreamhouses, playsets, games, and pink convertibles are made from and wrapped in. With over a billion dolls sold worldwide and a new...
by EpicentRx | Jul 11, 2023 | Blog
The First Amendment to the U.S. Constitution guarantees the right to freedom of expression. (See blog post entitled, AdAPT-001 and the Bill of Rights.) AdAPT-001, a modified common cold adenovirus, which carries a transforming growth factor-beta (TGF-β) trap,...
by EpicentRx | Jul 10, 2023 | Blog
“WOW (Word of the Week) your friends” Nibrozetone Definition: Noun: The international nonproprietary name (INN) for RRx-001. Example sentence: “Nibrozetone (RRx-001) plus a platinum doublet is under evaluation in a Phase 3 small cell lung cancer (SCLC) trial called...
by EpicentRx | Jul 6, 2023 | 2023, Press Releases
New USAN name, a shortening of its chemical name, signifies a novel therapeutic class Novel generic name highlights the anti-inflammatory, anticancer, and antioxidant properties of RRx-001 and its potential to address several diverse unmet therapeutic needs TORREY...
by EpicentRx | Jul 6, 2023 | Blog
Welcome back, everyone. We hope you enjoyed a fun and safe 4th of July. Did you know that the right to assemble in the name of fun, franks, fireworks, and fender-to-fender traffic this 4th was guaranteed not by the 1776 Declaration of Independence document but by the...